Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2022-10-03 00:00:00 ET · period of report 2022-09-30 · accession 0001437749-22-023512 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-03 | 2022-09-30 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.98 | +1,000 | 7,709 | +15% | +$5,980 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-30 | P | A | 400 | $5.98 | 8,109 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-30 | P | A | 600 | $5.98 | 7,709 | D | — | — |